Hepatic Cancer
Also known as: Malignant Liver Tumors / Liver Malignant Tumors / Malignant Tumor Liver / Hepatic neoplasms malignant / Malignant Liver Tumor / Hepatic Neoplasm Malignant / Malignant Liver Neoplasm / Malignant neoplasm of liver, not specified as primary or secondary / Hepatic tumour malignant / Hepatic tumor malignant / Liver, cancer of / Cancer of Liver / Malignant liver tumour / Hepatic neoplasm malignant NOS / Malignant hepatic neoplasm / Malignant neoplasm of liver (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15169 | H3B-6527 | 1 | Completed | 1 |
| DB02325 | Isopropyl alcohol | 1 | Terminated | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB16364 | Recombinant Human Thrombopoietin | 1 / 2 | Completed | 1 |
| DB00322 | Floxuridine | 2 | Completed | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |
| DB15101 | Tigatuzumab | 2 | Completed | 1 |
| DB14922 | Tislelizumab | 2 | Recruiting | 1 |
| DB01101 | Capecitabine | 3 | Withdrawn | 1 |
| DB00526 | Oxaliplatin | 3 | Withdrawn | 1 |
| DB00398 | Sorafenib | 3 | Withdrawn | 1 |
| DB11735 | Galactose | 4 | Withdrawn | 1 |